EMA wants comment on rule to identify API imports; FDA warns German devicemaker;

> The European Medicines Agency is giving drug manufacturers until June 1 to comment on its draft guidance for written confirmation of API imports from outside Europe, which it is introducing to protect against counterfeit drugs. Item

> The FDA has issued a warning letter to German device maker I.E.M. for an array of problems at its plant in Stolberg. Story

> The United States Pharmacopoeia (USP) will work with the South Korea Food and Drug Administration (KFDA) on quality standards for drug manufacturing. Item

> Major pharmaceutical manufacturers in Jammu, India, are asking the government to add infrastructure and educational opportunities in the area to help companies better compete in the world market. Story


Suggested Articles

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.